| Page 8 | NAHRI

Medicare could have saved over $200 million in payments for definitive drug testing services between 2016 and 2020 if proper program safeguards had been in place, according to a recent audit report by the Office of Inspector General (OIG).Read More »

Revenue Integrity Insider

Majority of hospitals remain noncompliant with price transparency requirements

Wednesday, February 15, 2023

Compliance, Monitoring and Audits, News, Policies and Procedures

Over three-quarters of hospitals remain noncompliant with federal price transparency regulations, according to a PatientRightsAdvocate.org report.Read More »

Leadership Council Insider

Planning for the end of PHE waivers

Friday, January 20, 2023

Billing and Claims, Compliance, Monitoring and Audits, NAHRI Leadership Council, Policies and Procedures, Reimbursement and Payment Methodologies, Revenue Integrity

As we start 2023, one of the biggest questions is the fate of the COVID-19 public health emergency declaration (PHE).Read More »

NAHRI Journal - Volume 7, Issue 1

Unlocking key changes in the 2023 MPFS final rule

Wednesday, January 18, 2023

Billing and Claims, Chargemaster and Charge Capture, Coding and Documentation, Compliance, Coverage, Monitoring and Audits, Reimbursement and Payment Methodologies, Revenue Integrity

Ensure you’re complying with new rules for billing and coding.Read More »

NAHRI Journal - Volume 7, Issue 1

Weighing gains and losses in the 2023 OPPS final rule

Wednesday, January 18, 2023

Billing and Claims, Chargemaster and Charge Capture, Coding and Documentation, Compliance, Coverage, Monitoring and Audits, Reimbursement and Payment Methodologies, Revenue Integrity

Learn how CMS’ changes will affect hospital reimbursement.Read More »

Pages